Posts

Mapping the core senescence phenotype of human colon fi...

“[…] despite the impact of aging on colon health and colon cancer, an atlas of t...

Remote height and weight measurements for children prov...

BATON ROUGE – The increased popularity of telehealth and telemedicine in recent ...

Wildfire smoke disproportionately affects California’s ...

Researchers using a novel method of measuring long-term wildfire smoke exposure ...

Notre Dame literacy research can improve learning outco...

A new study by a team of University of Notre Dame researchers makes a significan...

Discovery of proteins associated with the progression o...

Niigata, Japan –Dialysis patients often develop dialysis-related amyloidosis and...

Innovative domain-adaptive method enables 3D face recon...

Reconstructing a 3D face from visuals is crucial for digital face modeling and m...

Groundbreaking study unveils unique roles of yeast prot...

Assistant Professor Takahiro Kosugi of Institute for Molecular Science, assistan...

Study Shows Roche’s Xolair Diminishes Severe Food Aller...

Xolair, a medication jointly marketed by Roche and Novartis, has emerged as a so...

275 Million New Genetic Variants Discovered by Researchers

In a recent investigation, scientists scrutinized the genetic composition of 250...

Bristol Myers Squibb Expands Irish Campus with $400M In...

Bristol Myers Squibb (BMS) has disclosed a significant infusion of $400 million ...

Breakthrough Antibiotic Shows Promise Against Resistant...

Amidst the concerning rise of drug-resistant strains of gonorrhea, a recent brea...

Grifols prepares for late-stage plans with plasma-deriv...

In an interview with Pharmaceutical Technology, the company’s chief scientific o...

Biotechs heed political headwinds for drug pricing nego...

Biotechs need to navigate US-China relations when pursuing collaborations and dr...

Biotech execs say IRA is causing unintended effects for...

IRA regulations have changed how pharma is approaching innovation in cancer drug...

Beyond approval: Patients pursue alternate paths to get...

As post-approval boundaries disproportionately affect rare disease patients, com...

EMA and FDA green-light MoonLake to advance IL-17 inhib...

The Phase III VELA programme will compare the IL-17 inhibitor sonelokimab to a p...